These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 1337875
1. Effect of verapamil on acute coxsackievirus B3 murine myocarditis. Xu Y, Yang YZ, Chen HZ, Jin PY, Guo Q, Zhao WZ, Yang JH, Cai QX, Zhou YC. Chin Med J (Engl); 1992 Oct; 105(10):818-21. PubMed ID: 1337875 [Abstract] [Full Text] [Related]
2. [Inhibitory effect of Chinese herbal medicine Xin-Kang oral liquid on replication of CVB3 RNA in Coxsackievirus B3 infected mice]. Wan SJ, Yang F, Huang XZ. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):238-40. PubMed ID: 17971932 [Abstract] [Full Text] [Related]
3. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration. Song X, Liu Z, Wang H, Xin Y, Wang X, Chen J, Shi Y, Zhang C, Hui R. Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068 [Abstract] [Full Text] [Related]
4. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. Yun SH, Lee WG, Kim YC, Ju ES, Lim BK, Choi JO, Kim DK, Jeon ES. J Infect Dis; 2012 Feb 01; 205(3):491-7. PubMed ID: 22207647 [Abstract] [Full Text] [Related]
9. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response. Dai Q, He X, Yu H, Bai Y, Jiang L, Sheng H, Peng J, Wang M, Yu J, Zhang K. J Med Virol; 2021 Jun 01; 93(6):3581-3589. PubMed ID: 33336842 [Abstract] [Full Text] [Related]
11. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis. Hiraoka Y, Kishimoto C, Kurokawa M, Ochiai H, Sasayama S. J Pharmacol Exp Ther; 1992 Mar 01; 260(3):1386-91. PubMed ID: 1372051 [Abstract] [Full Text] [Related]
12. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication. Zhao Y, Yan K, Wang Y, Cai J, Wei L, Li S, Xu W, Li M. Microb Pathog; 2020 Jul 01; 144():104169. PubMed ID: 32205210 [Abstract] [Full Text] [Related]
13. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L, He X, Gao B, Xiong S. J Virol; 2015 Oct 01; 89(20):10512-23. PubMed ID: 26269170 [Abstract] [Full Text] [Related]
16. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice. Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P. J Med Virol; 2007 Sep 01; 79(9):1334-42. PubMed ID: 17607777 [Abstract] [Full Text] [Related]
18. The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3. Fengqin L, Yulin W, Xiaoxin Z, Youpeng J, Yan C, Qing-qing W, Hong C, Jia S, Lei H. J Ethnopharmacol; 2010 Feb 03; 127(2):221-8. PubMed ID: 19932162 [Abstract] [Full Text] [Related]
19. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice. Jiang Y, Zhu R, Luo L, Mu Q, Zhu Y, Luo H, Zou X, Shen X. Intervirology; 2015 Feb 03; 58(6):343-9. PubMed ID: 26829552 [Abstract] [Full Text] [Related]